• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症监护病房中多重耐药革兰氏阴性杆菌的趋势及延长β-内酰胺类药物输注时间的作用。

Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit.

作者信息

Guervil David J, Chau Terence

机构信息

Department of Pharmacy, Memorial Hermann-Texas Medical Center, Houston, 77030, USA.

出版信息

Crit Care Nurs Q. 2013 Oct-Dec;36(4):345-55. doi: 10.1097/CNQ.0b013e3182a10d2f.

DOI:10.1097/CNQ.0b013e3182a10d2f
PMID:24002425
Abstract

Multidrug-resistant gram-negative bacilli are emerging threats in the intensive care unit setting worldwide. Extended-spectrum β-lactamases, AmpC β-lactamases, and carbapenem-resistant Enterobacteriaceae are increasing at an alarming rate, leaving limited therapeutic options. In addition, multidrug resistance among Pseudomonas aeruginosa and Acinetobacter baumannii has widely disseminated and become a frequent cause of nosocomial infections within many intensive care units. Therefore, resistance is increasing to all currently available antibiotics, including cephalosporins, penicillins, aztreonam, carbapenems, fluoroquinolones, and aminoglycosides. Some multidrug-resistant gram-negative bacteria remain susceptible to only a few antibiotics such as tigecycline, fosfomycin, and polymyxins. The steady trend of increasing resistance coupled with the lack of novel antibiotics targeting resistant gram-negative bacilli has forced clinicians to increasingly apply more aggressive dosing strategies, such as prolonged and continuous infusion of β-lactam antibiotics to address the challenges associated with these difficult-to-treat pathogens. Nurses who have a thorough understanding of antibiotic resistance patterns, infection control procedures, and appropriate antibiotic use and dosing regimens, particularly the method of administration, are essential in the battle to preserve the usefulness of antibiotics and prevent further antibiotic resistance.

摘要

多重耐药革兰氏阴性杆菌在全球范围内的重症监护病房中构成了新的威胁。超广谱β-内酰胺酶、AmpCβ-内酰胺酶和耐碳青霉烯类肠杆菌科细菌正以惊人的速度增加,使得治疗选择极为有限。此外,铜绿假单胞菌和鲍曼不动杆菌的多重耐药性已广泛传播,成为许多重症监护病房医院感染的常见原因。因此,目前所有可用抗生素,包括头孢菌素、青霉素、氨曲南、碳青霉烯类、氟喹诺酮类和氨基糖苷类的耐药性都在增加。一些多重耐药革兰氏阴性菌仅对少数抗生素敏感,如替加环素、磷霉素和多粘菌素。耐药性持续上升的趋势,加上缺乏针对耐药革兰氏阴性杆菌的新型抗生素,迫使临床医生越来越多地采用更积极的给药策略,如延长和持续输注β-内酰胺类抗生素,以应对与这些难以治疗的病原体相关的挑战。对抗生素耐药模式、感染控制程序以及适当的抗生素使用和给药方案,特别是给药方法有透彻了解的护士,对于维护抗生素的有效性和防止进一步的抗生素耐药性至关重要。

相似文献

1
Trends in multidrug-resistant gram-negative bacilli and the role of prolonged β-lactam infusion in the intensive care unit.重症监护病房中多重耐药革兰氏阴性杆菌的趋势及延长β-内酰胺类药物输注时间的作用。
Crit Care Nurs Q. 2013 Oct-Dec;36(4):345-55. doi: 10.1097/CNQ.0b013e3182a10d2f.
2
The current state of multidrug-resistant gram-negative bacilli in North America.北美多重耐药革兰氏阴性杆菌的现状。
Pharmacotherapy. 2008 Feb;28(2):235-49. doi: 10.1592/phco.28.2.235.
3
Emerging issues in the management of infections caused by multi-drug-resistant, gram-negative bacilli.多重耐药革兰氏阴性杆菌感染管理中的新问题。
Surg Infect (Larchmt). 2005;6 Suppl 2:S-37-47.
4
An update on the management of urinary tract infections in the era of antimicrobial resistance.抗菌药物耐药时代泌尿道感染管理的最新进展
Postgrad Med. 2017 Mar;129(2):242-258. doi: 10.1080/00325481.2017.1246055. Epub 2016 Oct 21.
5
New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.耐多药铜绿假单胞菌和其他非发酵革兰阴性杆菌引起感染的新治疗选择。
Semin Respir Crit Care Med. 2011 Apr;32(2):151-8. doi: 10.1055/s-0031-1275527. Epub 2011 Apr 19.
6
[Broad-spectrum beta-lactamases in Gram-negative bacteria].革兰氏阴性菌中的广谱β-内酰胺酶
Tidsskr Nor Laegeforen. 2008 Dec 4;128(23):2741-5.
7
Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.医院获得性感染中出现的耐药革兰氏阴性需氧杆菌。
Chemotherapy. 2010;56(6):492-500. doi: 10.1159/000321018. Epub 2010 Nov 24.
8
Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.基于药代动力学/药效学的重症监护病房革兰氏阴性菌肺部感染β-内酰胺类治疗方案比较
J Antimicrob Chemother. 2005 Nov;56(5):893-8. doi: 10.1093/jac/dki335. Epub 2005 Sep 14.
9
Management of antibiotic resistance in the intensive care unit setting.重症监护病房抗生素耐药管理。
Expert Rev Anti Infect Ther. 2010 Mar;8(3):289-302. doi: 10.1586/eri.10.7.
10
Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.非发酵革兰氏阴性菌的耐药性:最大程度的多重耐药。
Am J Infect Control. 2006 Jun;34(5 Suppl 1):S29-37; discussion S64-73. doi: 10.1016/j.ajic.2006.05.226.

引用本文的文献

1
Biofilm Production in Intensive Care Units: Challenges and Implications.重症监护病房中的生物膜形成:挑战与影响
Pathogens. 2024 Nov 1;13(11):954. doi: 10.3390/pathogens13110954.
2
Piperacillin-Tazobactam versus Cefotaxime as Empiric Treatment for Febrile Urinary Tract Infection in Hospitalized Children.哌拉西林-他唑巴坦与头孢噻肟作为住院儿童发热性尿路感染经验性治疗的比较
Infect Chemother. 2024 Jun;56(2):266-275. doi: 10.3947/ic.2024.0020.
3
Burden of severe infections due to carbapenem-resistant pathogens in intensive care unit.重症监护病房中耐碳青霉烯类病原体所致严重感染的负担
World J Clin Cases. 2023 May 6;11(13):2874-2889. doi: 10.12998/wjcc.v11.i13.2874.
4
Optimal infusion rate in antimicrobial therapy explosion of evidence in the last five years.抗菌治疗中的最佳输注速率:过去五年证据激增。
Infect Drug Resist. 2018 Aug 8;11:1105-1117. doi: 10.2147/IDR.S167616. eCollection 2018.
5
Prevalence of extensively drug-resistant gram negative bacilli in surgical intensive care in Egypt.埃及外科重症监护病房中广泛耐药革兰氏阴性杆菌的患病率。
Pan Afr Med J. 2014 Oct 21;19:177. doi: 10.11604/pamj.2014.19.177.4307. eCollection 2014.
6
Detecting specific infections in children through host responses: a paradigm shift.通过宿主反应检测儿童特定感染:一种范式转变。
Curr Opin Infect Dis. 2014 Jun;27(3):228-35. doi: 10.1097/QCO.0000000000000065.